{"id":"114144232470-50","name":"European Society for Radiotherapy and Oncology","registrationDate":"2018-09-21T12:47:44.551+02:00","category":3,"subCategory":2,"legal":"VZW","web":"https://www.estro.org","country":"Belgium","headAddress":"Rue Martin V. 40","headCity":"Brussels","headPostCode":"1200","headPhone":"(32)27 75 93 40","boss":"Gasparotto Chiara","bossTitle":"Ms","bossPosition":"Director of Policy and Partnership","membersCount":4,"membersFTE":"3.0","membership":"","memberOrga":"Membership structure: https://www.estro.org/members&#xd;\n&#xd;\nApprox 100 countries representing members 2018 and 160 countries representing the ESTRO community.","goal":"The mission of ESTRO, a non-profit, scientific organisation, shall be to foster, in all its aspects, radiotherapy (also known as radiation oncology), clinical oncology and related subjects, including physics as applied to radiotherapy, radiation technology and radiobiology.&#xd;<br />&#xd;<br />To fulfil its mission ESTRO will:&#xd;<br />-Develop and promote standards of education in radiotherapy and clinical oncology&#xd;<br />-Promote standards of practice in radiotherapy, clinical oncology and related subjects&#xd;<br />-Stimulate the exchange of scientific knowledge in all related fields&#xd;<br />-Strengthen the clinical specialty of radiotherapy and clinical oncology in relation to other specialties and professions involved in cancer management&#xd;<br />-Encourage co-operation with international, regional and national societies and bodies representing radiotherapy, clinical oncology and related subjects &#xd;<br />-Facilitate research and development in radiotherapy, clinical oncology and related subjects.","acronym":"ESTRO","interests":"Education and training, Energy, Public Health, Research and innovation","euInitiatives":"•\tCANCON www.cancercontrol.eu  &#xd;<br />•\tIPAAC Innovative Partnership for Actions Against Cancer https://www.ipaac.eu &#xd;<br />•\tJARC Joint Action on Cancer (together with SIOPE https://www.siope.eu/)&#xd;<br />•\tERN European Reference Network http://www.ern-rnd.eu/ &#xd;<br />•\tIMI Innovative Medicines Agency https://www.imi.europa.eu/ &#xd;<br />&#xd;<br />•\tCOUNCIL DIRECTIVE 2013/59/EURATOM of 5 December 2013 laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation, and repealing Directives 89/618/Euratom, 90/641/ ARTICLE 63 + 78&#xd;<br />•\tDirective 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross-border healthcare&#xd;<br />•\tDirective 2013/35/EU of the European Parliament and of the Council of 26 June 2013 on the minimum health and safety requirements regarding the exposure of workers to the risks arising from physical agents (electromagnetic fields) &#xd;<br />•\tRegulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU &#xd;<br />•\tRegulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC","lastUp":"2018-09-21T12:48:33.575+02:00","customers":"","costAbsolu":"","costRange":"200000-299999","turnoverAbsolu":0,"turnoverRange":""}